Search Results
Second Generation INSTI Regimens for Drug Naive Patients: State-of-the-Art | Daniel Kuritzkes, MD
Resistance considerations when choosing INSTIs - Daniel Kuritzkes, MD
State of the Art: Resistance to INSTI | Anne-Geneviève Marcelin, PharmD, PhD,
Impact on: Virology/Resistance | Daniel Kuritzkes, MD
Debate: Integrase Inhibitors Cause Weight Gain - Daniel Kuritzkes, MD
Next Steps to Eradication by Daniel R. Kuritzkes, MD
State of the Art: Clinical Pharmacology of INSTI | Andrea Calcagno, MD, DTM&H
Session I - Managing Complex HIV Patients - European Editon
Interactive Antiretroviral Therapy Cases
Weight Gain, Genetics and INSTI use - Consideration for Selecting Therapy -Jessica Castilho, MD, MPH
CGT4HIVCURE2019: ROBERT SILICIANO (KEYNOTE)
Antiretroviral Drug Resistance in Pediatrics: Extent of the Problem and (...) -Natella Rakhmanina